澳大利亚科学家的目标是利用人工智能和75 000名病人提供的数据,针对遗传和遗传原因来治愈哮喘。 Australian scientists aim to cure asthma by targeting genetic and epigenetic causes using AI and data from 75,000 patients.

澳大利亚研究人员正在利用人工智能、遗传学和来自75 000多名病人的数据,寻求治疗哮喘,这挑战了长期认为哮喘无法治愈的信念。 Australian researchers are pursuing a cure for asthma using AI, genetics, and data from over 75,000 patients, challenging the long-held belief that asthma cannot be cured. 在墨尔本Cure Asthma专题讨论会上,科学家正在制订一个国家路线图,以确定哮喘的生物亚型,重点是可能永久改变肺和免疫功能的早期接触的遗传变化。 At the Cure Asthma Symposium in Melbourne, scientists are developing a national roadmap to identify biological subtypes of asthma, focusing on epigenetic changes from early-life exposures that may permanently alter lung and immune function. 他们的目标是扭转或防止这些分子缺陷,以便找到一种真正的治疗方法,被定义为没有药物的持久症状自由。 Their goal is to reverse or prevent these molecular defects, aiming for a true cure defined as lasting symptom freedom without medication.